SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000884731-17-000004
Filing Date
2017-01-17
Accepted
2017-01-17 17:06:52
Documents
3
Period of Report
2017-01-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_148469079934747.html 4  
1 FORM 4 wf-form4_148469079934747.xml 4 7539
2 PARIS POA paris_.htm EX-24 579
3 PARIS POA paris_001.jpg GRAPHIC 216319
  Complete submission text file 0000884731-17-000004.txt   307582
Mailing Address 125 BINNEY STREET CAMBRIDGE MA 02142
Business Address 125 BINNEY STREET CAMBRIDGE MA 02142 6174940400
ARIAD PHARMACEUTICALS INC (Issuer) CIK: 0000884731 (see all company filings)

IRS No.: 223106987 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address ARIAD PHARMACEUTICALS, INC. 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address
Panayiotopoulos Paris (Reporting) CIK: 0001662996 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36172 | Film No.: 17531360